Form EFFECT Aprea Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EvoEndo® Surpasses 3,000 Sedation-Free Transnasal Endoscopy Procedures Nationwide
- Silent Push Names Kirk Appelman Senior Vice President, Global Sales
- Queens Personal Injury Attorney Keetick L. Sanchez Explains the 90/180-Day Rule Under New York’s No-Fault Insurance Law
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
